Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
π Abstract
Abstract: Positron emission tomography (PET) with 18F-Fluorodeoxyglucose (FDG) is an
established tool in the diagnostic workup of patients with suspected dementing
disorders. However, compared to the routinely available magnetic resonance
imaging (MRI), FDG-PET remains significantly less accessible and substantially
more expensive. Here, we present SiM2P, a 3D diffusion bridge-based framework
that learns a probabilistic mapping from MRI and auxiliary patient information
to simulate FDG-PET images of diagnostic quality. In a blinded clinical reader
study, two neuroradiologists and two nuclear medicine physicians rated the
original MRI and SiM2P-simulated PET images of patients with Alzheimer's
disease, behavioral-variant frontotemporal dementia, and cognitively healthy
controls. SiM2P significantly improved the overall diagnostic accuracy of
differentiating between three groups from 75.0% to 84.7% (p<0.05). Notably, the
simulated PET images received higher diagnostic certainty ratings and achieved
superior interrater agreement compared to the MRI images. Finally, we developed
a practical workflow for local deployment of the SiM2P framework. It requires
as few as 20 site-specific cases and only basic demographic information. This
approach makes the established diagnostic benefits of FDG-PET imaging more
accessible to patients with suspected dementing disorders, potentially
improving early detection and differential diagnosis in resource-limited
settings. Our code is available at https://github.com/Yiiitong/SiM2P.
Authors (8)
Yitong Li
Ralph Buchert
Benita Schmitz-Koep
Timo Grimmer
BjΓΆrn Ommer
Dennis M. Hedderich
+2 more
Submitted
October 17, 2025
Key Contributions
This paper introduces SiM2P, a 3D diffusion bridge-based framework that simulates clinical-grade FDG-PET images from MRI and auxiliary patient data. This approach significantly improves diagnostic accuracy for dementing disorders, offering a more accessible and less expensive alternative to actual PET scans.
Business Value
Increases accessibility to crucial diagnostic information for dementia, potentially leading to earlier and more accurate diagnoses, improved patient outcomes, and reduced healthcare costs.